Flere Fablyn- behandlede patienter (7, 0%) end placebobehandlede patienter (2, 7%) fik foretaget en diagnostisk procedure.
More FABLYN-treated patients (7.0%) had a diagnostic procedure compared to placebo-treated patients (2.7%).